98 related articles for article (PubMed ID: 23036870)
21. Dibenzylideneacetones Are Potent Trypanocidal Compounds That Affect the Trypanosoma cruzi Redox System.
Lazarin-Bidóia D; Desoti VC; Martins SC; Ribeiro FM; Ud Din Z; Rodrigues-Filho E; Ueda-Nakamura T; Nakamura CV; de Oliveira Silva S
Antimicrob Agents Chemother; 2016 Feb; 60(2):890-903. PubMed ID: 26596953
[TBL] [Abstract][Full Text] [Related]
22. L-proline is essential for the intracellular differentiation of Trypanosoma cruzi.
Tonelli RR; Silber AM; Almeida-de-Faria M; Hirata IY; Colli W; Alves MJ
Cell Microbiol; 2004 Aug; 6(8):733-41. PubMed ID: 15236640
[TBL] [Abstract][Full Text] [Related]
23. Amastigotes of Trypanosoma cruzi sustain an infective cycle in mammalian cells.
Ley V; Andrews NW; Robbins ES; Nussenzweig V
J Exp Med; 1988 Aug; 168(2):649-59. PubMed ID: 3045248
[TBL] [Abstract][Full Text] [Related]
24. Trypanocidal activity of 5,6-dihydropyran-2-ones against free trypomastigotes forms of Trypanosoma cruzi.
de Fátima A; Marquissolo C; de Albuquerque S; Carraro-Abrahão AA; Pilli RA
Eur J Med Chem; 2006 Oct; 41(10):1210-3. PubMed ID: 16815596
[TBL] [Abstract][Full Text] [Related]
25. Trypanosoma cruzi: trypanocidal effect of 2(3)-tert-butyl-4-hydroxyanisole (BHA) on several strains of epimastigote and trypomastigote forms.
Aldunate J; Ojeda JM; Repetto Y; Letelier ME; Spencer P
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1994 Oct; 109(2):119-27. PubMed ID: 7881815
[TBL] [Abstract][Full Text] [Related]
26. Trypanosoma cruzi: desferrioxamine decreases mortality and parasitemia in infected mice through a trypanostatic effect.
Arantes JM; Francisco AF; de Abreu Vieira PM; Silva M; Araújo MS; de Carvalho AT; Pedrosa ML; Carneiro CM; Tafuri WL; Martins-Filho OA; Elói-Santos SM
Exp Parasitol; 2011 Aug; 128(4):401-8. PubMed ID: 21620835
[TBL] [Abstract][Full Text] [Related]
27. Diterpenoid alkaloid derivatives as potential chemotherapeutic agents in American trypanosomiasis.
González P; Marín C; Rodríguez-González I; Illana A; Mateo H; Longoni SS; Rosales MJ; González-Coloma A; Reina M; Sánchez-Moreno M
Pharmacology; 2006; 76(3):123-8. PubMed ID: 16391494
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of naphthofuranquinones with activity against Trypanosoma cruzi.
Silva RS; Costa EM; Trindade UL; Teixeira DV; Pinto Mde C; Santos GL; Malta VR; De Simone CA; Pinto AV; de Castro SL
Eur J Med Chem; 2006 Apr; 41(4):526-30. PubMed ID: 16500733
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi.
Leite AC; Moreira DR; Cardoso MV; Hernandes MZ; Alves Pereira VR; Silva RO; Kiperstok AC; Lima Mda S; Soares MB
ChemMedChem; 2007 Sep; 2(9):1339-45. PubMed ID: 17628867
[TBL] [Abstract][Full Text] [Related]
30. Effects of a putrescine analog on Giardia lamblia.
Maia C; Lanfredi-Rangel A; Santana-Anjos KG; Oliveira MF; De Souza W; Vannier-Santos MA
Parasitol Res; 2008 Jul; 103(2):363-70. PubMed ID: 18437421
[TBL] [Abstract][Full Text] [Related]
31. Effects of treatment of trypomastigote forms of Trypanosoma cruzi or host cells with ethidium bromide on cell infection and intracellular fate of the parasite.
Lima MF; Kierszenbaum F
J Parasitol; 1984 Dec; 70(6):911-7. PubMed ID: 6396395
[TBL] [Abstract][Full Text] [Related]
32. Changes in polypeptide expression following Trypanosoma cruzi differentiation from trypomastigotes to amastigotes.
Ruiz-Ruano A; Villalta F; Lima MF
Biochem Int; 1991 Sep; 25(1):101-8. PubMed ID: 1772436
[TBL] [Abstract][Full Text] [Related]
33. Starvation and rapamycin differentially regulate host cell lysosome exocytosis and invasion by Trypanosoma cruzi metacyclic forms.
Martins RM; Alves RM; Macedo S; Yoshida N
Cell Microbiol; 2011 Jul; 13(7):943-54. PubMed ID: 21501360
[TBL] [Abstract][Full Text] [Related]
34. Trypanosoma cruzi infection by oral route: how the interplay between parasite and host components modulates infectivity.
Yoshida N
Parasitol Int; 2008 Jun; 57(2):105-9. PubMed ID: 18234547
[TBL] [Abstract][Full Text] [Related]
35. Trypanocidal activity of the ethyl esters of N-propyl and N-isopropyl oxamates on intracellular amastigotes of Trypanosoma cruzi acute infected mice.
Aguirre-Alvarado C; Zaragoza-Martínez F; Rodríguez-Páez L; Téllez-Rendón JL; Nogueda B; Baeza I; Wong C
J Enzyme Inhib Med Chem; 2010 Feb; 25(1):111-5. PubMed ID: 20030515
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
37. Quantitative proteomics of Trypanosoma cruzi during metacyclogenesis.
de Godoy LM; Marchini FK; Pavoni DP; Rampazzo Rde C; Probst CM; Goldenberg S; Krieger MA
Proteomics; 2012 Aug; 12(17):2694-703. PubMed ID: 22761176
[TBL] [Abstract][Full Text] [Related]
38. Trypanosoma cruzi: activity of heterocyclic cationic molecules in vitro.
Pacheco MG; da Silva CF; de Souza EM; Batista MM; da Silva PB; Kumar A; Stephens CE; Boykin DW; Soeiro Mde N
Exp Parasitol; 2009 Sep; 123(1):73-80. PubMed ID: 19520077
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of iron-containing superoxide dismutase-A (TcFeSOD-A) enzyme in Trypanosoma cruzi population with in vitro-induced resistance to benznidazole.
Nogueira FB; Krieger MA; Nirdé P; Goldenberg S; Romanha AJ; Murta SM
Acta Trop; 2006 Nov; 100(1-2):119-32. PubMed ID: 17113553
[TBL] [Abstract][Full Text] [Related]
40. Trypanosoma cruzi: effect of protein kinase inhibitors and cytoskeletal protein organization and expression on host cell invasion by amastigotes and metacyclic trypomastigotes.
Procópio DO; da Silva S; Cunningham CC; Mortara RA
Exp Parasitol; 1998 Sep; 90(1):1-13. PubMed ID: 9709024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
